TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

Israel
RecruitingPHASE3

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Conditions

Transthyretin Amyloidosis With Cardiomyopathy

Locations
  • Clinical Trial Site, La Jolla, California, United States
  • Clinical Trial Site, Stanford, California, United States
  • Clinical Trial Site, Norwich, Connecticut, United States
  • Clinical Trial Site, Washington D.C., District of Columbia, United States
  • Clinical Trial Site, Brandon, Florida, United States
  • Clinical Trial Site, Miami, Florida, United States
  • Clinical Trial Site, Atlanta, Georgia, United States
  • Clinical Trial Site, Gainesville, Georgia, United States
  • Clinical Trial Site, Tucker, Georgia, United States
  • Clinical Trial Site, Indianapolis, Indiana, United States
  • Clinical Trial Site, Indianapolis, Indiana, United States
  • Clinical Trial Site, Kansas City, Kansas, United States
  • Clinical Trial Site, Baltimore, Maryland, United States
  • Clinical Trial Site, Boston, Massachusetts, United States
  • Clinical Trial Site, Boston, Massachusetts, United States
  • Clinical Trial Site, Detroit, Michigan, United States
  • Clinical Trial Site, Rochester, Minnesota, United States
  • Clinical Trial Site, St Louis, Missouri, United States
  • Clinical Trial Site, Manhasset, New York, United States
  • Clinical Trial Site, New York, New York, United States
  • Clinical Trial Site, New York, New York, United States
  • Clinical Trial Site, New York, New York, United States
  • Clinical Trial Site, The Bronx, New York, United States
  • Clinical Trial Site, Charlotte, North Carolina, United States
  • Clinical Trial Site, Cleveland, Ohio, United States
  • Clinical Trial Site, Lancaster, Pennsylvania, United States
  • Clinical Trial Site, Philadelphia, Pennsylvania, United States
  • Clinical Trial Site, Dallas, Texas, United States
  • Clinical Trial Site, Houston, Texas, United States
  • Clinical Trial Site, Plano, Texas, United States
  • Clinical Trial Site, Salt Lake City, Utah, United States
  • Clinical Trial Site, Charlottesville, Virginia, United States
  • Clinical Trial Site, Norfolk, Virginia, United States
  • Clinical Trial Site, Spokane, Washington, United States
  • Clinical Trial Site, Buenos Aires, Argentina
  • Clinical Trial Site, Buenos Aires, Argentina
  • Clinical Trial Site, Buenos Aires, Argentina
  • Clinical Trial Site, Buenos Aires, Argentina
  • Clinical Trial Site, Rosario, Argentina
  • Clinical Trial Site, Rosario, Argentina
  • Clinical Trial Site, Rosario, Argentina
  • Clinical Trial Site, Adelaide, Australia
  • Clinical Trial Site, Bedford Park, Australia
  • Clinical Trial Site, Box Hill, Australia
  • Clinical Trial Site, Chermside, Australia
  • Clinical Trial Site, Darlinghurst, Australia
  • Clinical Trial Site, Joondalup, Australia
  • Clinical Trial Site, Westmead, Australia
  • Clinical Trial Site, Braunau am Inn, Austria
  • Clinical Trial Site, Graz, Austria
  • Clinical Trial Site, Vienna, Austria
  • Clinical Trial Site, Vienna, Austria
  • Clinical Trial Site, Vienna, Austria
  • Clinical Trial Site, Wels, Austria
  • Clinical Trial Site, Aalst, Belgium
  • Clinical Trial Site, Bruges, Belgium
  • Clinical Trial Site, Brussels, Belgium
  • Clinical Trial Site, Dendermonde, Belgium
  • Clinical Trial Site, Genk, Belgium
  • Clinical Trial Site, Ghent, Belgium
  • Clinical Trial Site, Hasselt, Belgium
  • Clinical Trial Site, Leuven, Belgium
  • Clinical Trial Site, Liège, Belgium
  • Clinical Trial Site, Roeselare, Belgium
  • Clinical Trial Site, Belo Horizonte, Brazil
  • Clinical Trial Site, Porto Alegre, Brazil
  • Clinical Trial Site, Porto Alegre, Brazil
  • Clinical Trial Site, Ribeirão Preto, Brazil
  • Clinical Trial Site, Ribeirão Preto, Brazil
  • Clinical Trial Site, Salvador, Brazil
  • Clinical Trial Site, São Paulo, Brazil
  • Clinical Trial Site, São Paulo, Brazil
  • Clinical Trial Site, London, Canada
  • Clinical Trial Site, Santiago, Chile
  • Clinical Trial Site, Santiago, Chile
  • Clinical Trial Site, Dongcheng, China
  • Clinical Trial Site, Brno, Czechia
  • Clinical Trial Site, Ostrava, Czechia
  • Clinical Trial Site, Prague, Czechia
  • Clinical Trial Site, Aarhus N, Denmark
  • Clinical Trial Site, København Ø, Denmark
  • Clinical Trial Site, Odense C, Denmark
  • Clinical Trial Site, Chambray-lès-Tours, France
  • Clinical Trial Site, Dijon, France
  • Clinical Trial Site, La Tronche, France
  • Clinical Trial Site, Marseille, France
  • Clinical Trial Site, Martinique, France
  • Clinical Trial Site, Montpellier, France
  • Clinical Trial Site, Paris, France
  • Clinical Trial Site, Paris, France
  • Clinical Trial Site, Pessac, France
  • Clinical Trial Site, Reims, France
  • Clinical Trial Site, Rennes, France
  • Clinical Trial Site, Rouen, France
  • Clinical Trial Site, Saint-Herblain, France
  • Clinical Trial Site, Strasbourg, France
  • Clinical Trial Site, Toulouse, France
  • Clinical Trial Site, Berlin, Germany
  • Clinical Trial Site, Cologne, Germany
  • Clinical Trial Site, Göttingen, Germany
  • Clinical Trial Site, Hanover, Germany
  • Clinical Trial Site, Leipzig, Germany
  • Clinical Trial Site, Munich, Germany
  • Clinical Trial Site, Münster, Germany
  • Clinical Trial Site, Würzburg, Germany
  • Clinical Trial Site, Athens, Greece
  • Clinical Trial Site, Athens, Greece
  • Clinical Trial Site, Heraklion, Greece
  • Clinical Trial Site, Thessaloniki, Greece
  • Clinical Trial Site, Hong Kong, Hong Kong
  • Clinical Trial Site, Budapest, Hungary
  • Clinical Trial Site, Be’er Ya‘aqov, Israel
  • Clinical Trial Site, Haifa, Israel
  • Clinical Trial Site, Jerusalem, Israel
  • Clinical Trial Site, Petah Tikva, Israel
  • Clinical Trial Site, Ancona, Italy
  • Clinical Trial Site, Bologna, Italy
  • Clinical Trial Site, Brescia, Italy
  • Clinical Trial Site, Florence, Italy
  • Clinical Trial Site, Forlì, Italy
  • Clinical Trial Site, Milan, Italy
  • Clinical Trial Site, Naples, Italy
  • Clinical Trial Site, Padova, Italy
  • Clinical Trial Site, Pavia, Italy
  • Clinical Trial Site, Pisa, Italy
  • Clinical Trial Site, Rimini, Italy
  • Clinical Trial Site, Roma, Italy
  • Clinical Trial Site, Rome, Italy
  • Clinical Trial Site, Torino, Italy
  • Clinical Trial Site, Bunkyō City, Japan
  • Clinical Trial Site, Fukuoka, Japan
  • Clinical Trial Site, Fukuoka, Japan
  • Clinical Trial Site, Kagawa, Japan
  • Clinical Trial Site, Kashihara, Japan
  • Clinical Trial Site, Kobe, Japan
  • Clinical Trial Site, Kumamoto, Japan
  • Clinical Trial Site, Kurume, Japan
  • Clinical Trial Site, Matsumoto-shi, Japan
  • Clinical Trial Site, Nagoya, Japan
  • Clinical Trial Site, Nankoku, Japan
  • Clinical Trial Site, Niigata, Japan
  • Clinical Trial Site, Okayama, Japan
  • Clinical Trial Site, Sapporo, Japan
  • Clinical Trial Site, Sapporo, Japan
  • Clinical Trial Site, Sendai, Japan
  • Clinical Trial Site, Suita, Japan
  • Clinical Trial Site, Tokyo, Japan
  • Clinical Trial Site, Kajang, Malaysia
  • Clinical Trial Site, Kuala Lumpur, Malaysia
  • Clinical Trial Site, Eindhoven, Netherlands
  • Clinical Trial Site, Groningen, Netherlands
  • Clinical Trial Site, Maastricht, Netherlands
  • Clinical Trial Site, Rotterdam, Netherlands
  • Clinical Trial Site, Utrecht, Netherlands
  • Clinical Trial Site, Christchurch, New Zealand
  • Clinical Trial Site, Hamilton, New Zealand
  • Clinical Trial Site, Ålesund, Norway
  • Clinical Trial Site, Lørenskog, Norway
  • Clinical Trial Site, Carnaxide, Portugal
  • Clinical Trial Site, Creixomil, Portugal
  • Clinical Trial Site, Leiria, Portugal
  • Clinical Trial Site, Lisbon, Portugal
  • Clinical Trial Site, Lisbon, Portugal
  • Clinical Trial Site, Vila Real, Portugal
  • Clinical Trial Site, Viseu, Portugal
  • Clinical Trial Site, Bucharest, Romania
  • Clinical Trial Site, Cluj-Napoca, Romania
  • Clinical Trial Site, Košice, Slovakia
  • Clinical Trial Site, Incheon, South Korea
  • Clinical Trial Site, Seoul, South Korea
  • Clinical Trial Site, Seoul, South Korea
  • Clinical Trial Site, Seoul, South Korea
  • Clinical Trial Site, Seoul, South Korea
  • Clinical Trial Site, A Coruña, Spain
  • Clinical Trial Site, Barcelona, Spain
  • Clinical Trial Site, Barcelona, Spain
  • Clinical Trial Site, Bilbao, Spain
  • Clinical Trial Site, El Palmar, Spain
  • Clinical Trial Site, Huelva, Spain
  • Clinical Trial Site, Jaén, Spain
  • Clinical Trial Site, L'Hospitalet de Llobregat, Spain
  • Clinical Trial Site, Lleida, Spain
  • Clinical Trial Site, Madrid, Spain
  • Clinical Trial Site, Madrid, Spain
  • Clinical Trial Site, Palma de Mallorca, Spain
  • Clinical Trial Site, Pamplona, Spain
  • Clinical Trial Site, Salamanca, Spain
  • Clinical Trial Site, Santiago de Compostela, Spain
  • Clinical Trial Site, Valencia, Spain
  • Clinical Trial Site, Valencia, Spain
  • Clinical Trial Site, Vigo, Spain
  • Clinical Trial Site, Gothenburg, Sweden
  • Clinical Trial Site, Lund, Sweden
  • Clinical Trial Site, Solna, Sweden
  • Clinical Trial Site, Basel, Switzerland
  • Clinical Trial Site, Geneva, Switzerland
  • Clinical Trial Site, Lucerne, Switzerland
  • Clinical Trial Site, Sankt Gallen, Switzerland
  • Clinical Trial Site, New Taipei City, Taiwan
  • Clinical Trial Site, Taipei, Taiwan
  • Clinical Trial Site, Taipei, Taiwan
  • Clinical Trial Site, Bellshill, United Kingdom
  • Clinical Trial Site, Birmingham, United Kingdom
  • Clinical Trial Site, Cardiff, United Kingdom
  • Clinical Trial Site, London, United Kingdom
  • Clinical Trial Site, London, United Kingdom
  • Clinical Trial Site, Manchester, United Kingdom